Genetic & Immunological Aspects of Diabetes

It is believed that a large proportion of cases of type 1 diabetes result from the autoimmune destruction of the pancreatic β cells. Genetic marker that makes person susceptible to diabetes is located on chromosome 6, and it’s an HLA (human leukocyte antigen) complex. Several HLA complexes have been connected to type 1 diabetes, and if the people have one or more of those, may develop type 1diabities. Fulminant type 1 diabetes (FT1D) is a novel subtype of type 1 diabetes characterized by extremely rapid onset and complete deficiency of insulin due to the destruction of pancreatic β cells. It has been proposed that locally produced MCP-1 may be involved in the development of diabetic nephropathy
A study also suggests that diabetes might be linked to genetics. To date, numerous mutations have been shown to affect type 2 diabetes risks. Genes associated with type 2 diabetes are:
  • TCF7L2, which affects insulin secretion and glucose production
  • ABCC8, which helps regulate insulin
  • CAPN10, which is associated with type 2 diabetes risk in Mexican-Americans
  • GLUT2, which helps move glucose into the pancreas
  • GCGR, a glucagon hormone involved in glucose regulation

    Related Conference of Genetic & Immunological Aspects of Diabetes

    March 25-26, 2020

    29th World Diabetes & Heart Congress

    Tokyo, Japan
    March 30-31, 2020

    International Conference on Diabetes and Heart Diseases

    Hong Kong, Hong Kong
    April 13-14, 2020

    World Congress on Endocrinology and Metabolic Syndrome

    Auckland, Newzealand
    June 15-16, 2020

    29th European Diabetes Congress

    Barcelona, Spain
    July 06-07, 2020

    Annual Congress on Diabetes, Metabolism and Obesity

    Sydney, Australia
    July 15-16, 2020

    3rd Global Diabetes Summit

    Helsinki, Finland
    July 15-16, 2020

    28th International Diabetes and Healthcare Conference

    Helsinki, Finland
    August 17-18, 2020

    16th World Congress on Endocrinology & Diabetes

    Copenhagen, Denmark
    August 24-25, 2020

    Global Summit on Diabetes & Endocrinology

    Kyoto, Japan
    August 24-25, 2020

    Annual Summit on Diabetes and Endocrinology

    Barcelona, Spain
    September 22-23, 2020

    2nd Asia Pacific Endocrinology Congress

    Singapore City, Singapore
    September 28-29, 2020

    4th Annual Congress on Diabetes, Obesity and Its Complications

    Singapore City, Singapore
    October 04-05, 2020

    World Summit on Blood Glucose Monitoring

    Beijing, China
    October 07-08, 2020

    International Summit on Diabetes

    Barcelona, Spain
    October 14-15, 2020

    World Congress on Endocrinology & Diabetes

    Rome, Italy
    October 14-15, 2020

    Global Congress on Endocrinology and Gynecology

    Sydney, Australia
    October 30-31, 2020

    Annual Summit on Metabolomics

    Vancouver, Canada
    November 02-03, 2020

    5th European Summit on Diabetes and Endocrinology

    Paris, France
    November 09-10, 2020

    International Congress and Expo on Diabetic Care

    Bangkok, Thailand
    November 16-17, 2020

    World Congress and Expo on Diabetes

    Kyoto, Japan
    November 16-17, 2020

    2nd Asia Pacific Diabetes and Endocrinology Congress

    Brisbane, Australia
    November 18-19, 2020

    Annual congress on Diabetes and Endocrinology Congress

    Bangkok, Thailand
    December 07-08, 2020

    13th World Congress on Endocrinology and Metabolic Disorders

    Auckland, Newzealand

    Genetic & Immunological Aspects of Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in